nodes	percent_of_prediction	percent_of_DWPC	metapath
Dinoprostone—ABCC5—Fluorouracil—stomach cancer	0.112	0.176	CbGbCtD
Dinoprostone—SLCO3A1—Methotrexate—stomach cancer	0.0964	0.152	CbGbCtD
Dinoprostone—SLCO1C1—Methotrexate—stomach cancer	0.0616	0.0971	CbGbCtD
Dinoprostone—SLC22A7—Fluorouracil—stomach cancer	0.055	0.0866	CbGbCtD
Dinoprostone—ABCC4—Fluorouracil—stomach cancer	0.0537	0.0846	CbGbCtD
Dinoprostone—SLC22A7—Docetaxel—stomach cancer	0.042	0.0661	CbGbCtD
Dinoprostone—SLCO1B1—Irinotecan—stomach cancer	0.0379	0.0597	CbGbCtD
Dinoprostone—SLC22A11—Methotrexate—stomach cancer	0.0318	0.0501	CbGbCtD
Dinoprostone—SLC22A7—Methotrexate—stomach cancer	0.0303	0.0478	CbGbCtD
Dinoprostone—ABCC4—Methotrexate—stomach cancer	0.0296	0.0467	CbGbCtD
Dinoprostone—SLCO1A2—Methotrexate—stomach cancer	0.0212	0.0335	CbGbCtD
Dinoprostone—SLCO1B1—Methotrexate—stomach cancer	0.02	0.0316	CbGbCtD
Dinoprostone—SLC22A8—Methotrexate—stomach cancer	0.0185	0.0292	CbGbCtD
Dinoprostone—SLC22A6—Methotrexate—stomach cancer	0.0129	0.0203	CbGbCtD
Dinoprostone—CYP1A2—Fluorouracil—stomach cancer	0.0119	0.0188	CbGbCtD
Dinoprostone—PTGIR—blood vessel—stomach cancer	0.00278	0.0275	CbGeAlD
Dinoprostone—Bimatoprost—AKR1C3—stomach cancer	0.0026	0.819	CrCbGaD
Dinoprostone—PTGER4—hematopoietic system—stomach cancer	0.00248	0.0245	CbGeAlD
Dinoprostone—SLC51B—digestive system—stomach cancer	0.00236	0.0234	CbGeAlD
Dinoprostone—PTGER4—epithelium—stomach cancer	0.00227	0.0224	CbGeAlD
Dinoprostone—PTGER4—smooth muscle tissue—stomach cancer	0.00218	0.0216	CbGeAlD
Dinoprostone—SLC51B—endocrine gland—stomach cancer	0.00195	0.0193	CbGeAlD
Dinoprostone—PTGER1—pancreas—stomach cancer	0.00195	0.0193	CbGeAlD
Dinoprostone—PTGER3—smooth muscle tissue—stomach cancer	0.00185	0.0183	CbGeAlD
Dinoprostone—HPGDS—hematopoietic system—stomach cancer	0.00181	0.018	CbGeAlD
Dinoprostone—SLC51B—liver—stomach cancer	0.00176	0.0174	CbGeAlD
Dinoprostone—PTGER4—lymphoid tissue—stomach cancer	0.00174	0.0173	CbGeAlD
Dinoprostone—PTGER4—digestive system—stomach cancer	0.00172	0.0171	CbGeAlD
Dinoprostone—SLC51A—digestive system—stomach cancer	0.00169	0.0168	CbGeAlD
Dinoprostone—HPGDS—epithelium—stomach cancer	0.00166	0.0164	CbGeAlD
Dinoprostone—PTGER2—bone marrow—stomach cancer	0.00162	0.016	CbGeAlD
Dinoprostone—PTGIR—hematopoietic system—stomach cancer	0.00148	0.0146	CbGeAlD
Dinoprostone—PTGFR—smooth muscle tissue—stomach cancer	0.00148	0.0146	CbGeAlD
Dinoprostone—HPGDS—pancreas—stomach cancer	0.00148	0.0146	CbGeAlD
Dinoprostone—PTGER3—digestive system—stomach cancer	0.00146	0.0144	CbGeAlD
Dinoprostone—PTGER4—endocrine gland—stomach cancer	0.00142	0.0141	CbGeAlD
Dinoprostone—SLC51A—endocrine gland—stomach cancer	0.0014	0.0138	CbGeAlD
Dinoprostone—PTGER1—endocrine gland—stomach cancer	0.00138	0.0136	CbGeAlD
Dinoprostone—PTGIR—epithelium—stomach cancer	0.00135	0.0134	CbGeAlD
Dinoprostone—PTGIR—smooth muscle tissue—stomach cancer	0.0013	0.0129	CbGeAlD
Dinoprostone—CYP11A1—hematopoietic system—stomach cancer	0.00128	0.0127	CbGeAlD
Dinoprostone—HPGDS—lymphoid tissue—stomach cancer	0.00128	0.0126	CbGeAlD
Dinoprostone—HPGDS—digestive system—stomach cancer	0.00126	0.0125	CbGeAlD
Dinoprostone—SLC51A—liver—stomach cancer	0.00126	0.0125	CbGeAlD
Dinoprostone—PTGER3—endocrine gland—stomach cancer	0.00121	0.0119	CbGeAlD
Dinoprostone—PTGIR—pancreas—stomach cancer	0.0012	0.0119	CbGeAlD
Dinoprostone—SLCO2A1—epithelium—stomach cancer	0.00118	0.0117	CbGeAlD
Dinoprostone—HPGDS—bone marrow—stomach cancer	0.00116	0.0115	CbGeAlD
Dinoprostone—SLCO2A1—pancreas—stomach cancer	0.00105	0.0104	CbGeAlD
Dinoprostone—SLCO1B1—hematopoietic system—stomach cancer	0.00105	0.0104	CbGeAlD
Dinoprostone—HPGDS—endocrine gland—stomach cancer	0.00104	0.0103	CbGeAlD
Dinoprostone—PTGIR—digestive system—stomach cancer	0.00103	0.0102	CbGeAlD
Dinoprostone—PTGER2—lymph node—stomach cancer	0.001	0.00993	CbGeAlD
Dinoprostone—SLC22A11—digestive system—stomach cancer	0.001	0.00992	CbGeAlD
Dinoprostone—PTGER4—lymph node—stomach cancer	0.000984	0.00974	CbGeAlD
Dinoprostone—SLC22A7—digestive system—stomach cancer	0.000978	0.00968	CbGeAlD
Dinoprostone—SLCO4A1—pancreas—stomach cancer	0.000968	0.00958	CbGeAlD
Dinoprostone—SLC51A—lymph node—stomach cancer	0.000967	0.00957	CbGeAlD
Dinoprostone—PTGFR—endocrine gland—stomach cancer	0.000964	0.00954	CbGeAlD
Dinoprostone—HPGDS—liver—stomach cancer	0.00094	0.0093	CbGeAlD
Dinoprostone—SLCO2B1—hematopoietic system—stomach cancer	0.000925	0.00916	CbGeAlD
Dinoprostone—SLC22A2—digestive system—stomach cancer	0.00087	0.00862	CbGeAlD
Dinoprostone—PTGFR—liver—stomach cancer	0.000869	0.0086	CbGeAlD
Dinoprostone—SLCO1C1—endocrine gland—stomach cancer	0.000852	0.00844	CbGeAlD
Dinoprostone—SLCO1A2—hematopoietic system—stomach cancer	0.000851	0.00843	CbGeAlD
Dinoprostone—PTGIR—endocrine gland—stomach cancer	0.00085	0.00841	CbGeAlD
Dinoprostone—PTGER3—lymph node—stomach cancer	0.000834	0.00825	CbGeAlD
Dinoprostone—CYP19A1—hematopoietic system—stomach cancer	0.000831	0.00822	CbGeAlD
Dinoprostone—SLC22A11—endocrine gland—stomach cancer	0.000828	0.00819	CbGeAlD
Dinoprostone—SLCO4A1—digestive system—stomach cancer	0.000827	0.00818	CbGeAlD
Dinoprostone—ABCC4—hematopoietic system—stomach cancer	0.000819	0.00811	CbGeAlD
Dinoprostone—SLC22A8—hematopoietic system—stomach cancer	0.000813	0.00805	CbGeAlD
Dinoprostone—SLC22A7—endocrine gland—stomach cancer	0.000808	0.008	CbGeAlD
Dinoprostone—PTGIR—liver—stomach cancer	0.000766	0.00758	CbGeAlD
Dinoprostone—ABCC5—bone marrow—stomach cancer	0.000758	0.0075	CbGeAlD
Dinoprostone—SLCO3A1—endocrine gland—stomach cancer	0.00075	0.00742	CbGeAlD
Dinoprostone—SLC22A11—liver—stomach cancer	0.000746	0.00739	CbGeAlD
Dinoprostone—SLCO2A1—endocrine gland—stomach cancer	0.000743	0.00735	CbGeAlD
Dinoprostone—CYP11A1—endocrine gland—stomach cancer	0.000735	0.00727	CbGeAlD
Dinoprostone—SLC22A7—liver—stomach cancer	0.000729	0.00721	CbGeAlD
Dinoprostone—SLCO1B1—digestive system—stomach cancer	0.000727	0.0072	CbGeAlD
Dinoprostone—HPGDS—lymph node—stomach cancer	0.00072	0.00713	CbGeAlD
Dinoprostone—SLCO4A1—endocrine gland—stomach cancer	0.000683	0.00676	CbGeAlD
Dinoprostone—SLCO3A1—liver—stomach cancer	0.000676	0.00669	CbGeAlD
Dinoprostone—SLCO2A1—liver—stomach cancer	0.00067	0.00663	CbGeAlD
Dinoprostone—ABCC4—pancreas—stomach cancer	0.000667	0.0066	CbGeAlD
Dinoprostone—PTGFR—lymph node—stomach cancer	0.000666	0.0066	CbGeAlD
Dinoprostone—SLCO2B1—digestive system—stomach cancer	0.000643	0.00637	CbGeAlD
Dinoprostone—SLCO4A1—liver—stomach cancer	0.000616	0.0061	CbGeAlD
Dinoprostone—ABCC5—liver—stomach cancer	0.000612	0.00606	CbGeAlD
Dinoprostone—SLCO1B1—endocrine gland—stomach cancer	0.000601	0.00595	CbGeAlD
Dinoprostone—SLCO1A2—digestive system—stomach cancer	0.000592	0.00586	CbGeAlD
Dinoprostone—SLCO1C1—lymph node—stomach cancer	0.000589	0.00583	CbGeAlD
Dinoprostone—PTGIR—lymph node—stomach cancer	0.000587	0.00581	CbGeAlD
Dinoprostone—Dihomo-gamma-linolenic acid—PTGS2—stomach cancer	0.000574	0.181	CrCbGaD
Dinoprostone—ABCC4—digestive system—stomach cancer	0.00057	0.00564	CbGeAlD
Dinoprostone—CYP1A2—hematopoietic system—stomach cancer	0.000557	0.00551	CbGeAlD
Dinoprostone—SLCO1B1—liver—stomach cancer	0.000542	0.00536	CbGeAlD
Dinoprostone—SLCO2B1—endocrine gland—stomach cancer	0.000532	0.00526	CbGeAlD
Dinoprostone—ABCC4—bone marrow—stomach cancer	0.000525	0.0052	CbGeAlD
Dinoprostone—SLCO3A1—lymph node—stomach cancer	0.000518	0.00513	CbGeAlD
Dinoprostone—SLCO2A1—lymph node—stomach cancer	0.000513	0.00508	CbGeAlD
Dinoprostone—SLC22A1—endocrine gland—stomach cancer	0.000508	0.00503	CbGeAlD
Dinoprostone—CYP11A1—lymph node—stomach cancer	0.000508	0.00503	CbGeAlD
Dinoprostone—SLCO1A2—endocrine gland—stomach cancer	0.000489	0.00484	CbGeAlD
Dinoprostone—SLCO2B1—liver—stomach cancer	0.000479	0.00474	CbGeAlD
Dinoprostone—CYP19A1—endocrine gland—stomach cancer	0.000477	0.00473	CbGeAlD
Dinoprostone—SLCO4A1—lymph node—stomach cancer	0.000472	0.00467	CbGeAlD
Dinoprostone—ABCC4—endocrine gland—stomach cancer	0.000471	0.00466	CbGeAlD
Dinoprostone—ABCC5—lymph node—stomach cancer	0.00047	0.00465	CbGeAlD
Dinoprostone—SLC22A1—liver—stomach cancer	0.000458	0.00453	CbGeAlD
Dinoprostone—SLCO1A2—liver—stomach cancer	0.000441	0.00437	CbGeAlD
Dinoprostone—CYP19A1—liver—stomach cancer	0.00043	0.00426	CbGeAlD
Dinoprostone—ABCC4—liver—stomach cancer	0.000424	0.0042	CbGeAlD
Dinoprostone—CYP1A2—digestive system—stomach cancer	0.000387	0.00383	CbGeAlD
Dinoprostone—SLCO2B1—lymph node—stomach cancer	0.000367	0.00364	CbGeAlD
Dinoprostone—Cramps of lower extremities—Epirubicin—stomach cancer	0.000349	0.00306	CcSEcCtD
Dinoprostone—Bronchospasm—Docetaxel—stomach cancer	0.000348	0.00305	CcSEcCtD
Dinoprostone—Back pain—Irinotecan—stomach cancer	0.000344	0.00302	CcSEcCtD
Dinoprostone—Muscle spasms—Irinotecan—stomach cancer	0.000342	0.003	CcSEcCtD
Dinoprostone—Asthma—Capecitabine—stomach cancer	0.000342	0.003	CcSEcCtD
Dinoprostone—Bronchospasm—Capecitabine—stomach cancer	0.000336	0.00295	CcSEcCtD
Dinoprostone—Sweating increased—Capecitabine—stomach cancer	0.000333	0.00292	CcSEcCtD
Dinoprostone—Hypertonia—Epirubicin—stomach cancer	0.000333	0.00292	CcSEcCtD
Dinoprostone—Vaginal infection—Doxorubicin—stomach cancer	0.000332	0.00291	CcSEcCtD
Dinoprostone—CYP19A1—lymph node—stomach cancer	0.00033	0.00327	CbGeAlD
Dinoprostone—ABCC4—lymph node—stomach cancer	0.000325	0.00322	CbGeAlD
Dinoprostone—Cramps of lower extremities—Doxorubicin—stomach cancer	0.000323	0.00283	CcSEcCtD
Dinoprostone—Vision blurred—Fluorouracil—stomach cancer	0.000321	0.00282	CcSEcCtD
Dinoprostone—CYP1A2—endocrine gland—stomach cancer	0.00032	0.00317	CbGeAlD
Dinoprostone—Syncope—Irinotecan—stomach cancer	0.000319	0.0028	CcSEcCtD
Dinoprostone—Loss of consciousness—Irinotecan—stomach cancer	0.000313	0.00275	CcSEcCtD
Dinoprostone—Cough—Irinotecan—stomach cancer	0.000311	0.00273	CcSEcCtD
Dinoprostone—Acute coronary syndrome—Docetaxel—stomach cancer	0.000311	0.00272	CcSEcCtD
Dinoprostone—Myocardial infarction—Docetaxel—stomach cancer	0.000309	0.00271	CcSEcCtD
Dinoprostone—Hypertonia—Doxorubicin—stomach cancer	0.000308	0.0027	CcSEcCtD
Dinoprostone—Hypertension—Irinotecan—stomach cancer	0.000307	0.0027	CcSEcCtD
Dinoprostone—Eye pain—Epirubicin—stomach cancer	0.000305	0.00268	CcSEcCtD
Dinoprostone—Anaphylactoid reaction—Methotrexate—stomach cancer	0.000304	0.00267	CcSEcCtD
Dinoprostone—Acute coronary syndrome—Capecitabine—stomach cancer	0.000301	0.00264	CcSEcCtD
Dinoprostone—Myocardial infarction—Capecitabine—stomach cancer	0.000299	0.00262	CcSEcCtD
Dinoprostone—Hot flush—Epirubicin—stomach cancer	0.000295	0.00259	CcSEcCtD
Dinoprostone—Menopausal symptoms—Epirubicin—stomach cancer	0.000292	0.00256	CcSEcCtD
Dinoprostone—Anaphylactic shock—Irinotecan—stomach cancer	0.000291	0.00255	CcSEcCtD
Dinoprostone—Chest pain—Fluorouracil—stomach cancer	0.00029	0.00255	CcSEcCtD
Dinoprostone—Myalgia—Fluorouracil—stomach cancer	0.00029	0.00255	CcSEcCtD
Dinoprostone—CYP1A2—liver—stomach cancer	0.000288	0.00285	CbGeAlD
Dinoprostone—Shock—Irinotecan—stomach cancer	0.000286	0.00251	CcSEcCtD
Dinoprostone—Anaphylactoid reaction—Epirubicin—stomach cancer	0.000285	0.0025	CcSEcCtD
Dinoprostone—Eye pain—Doxorubicin—stomach cancer	0.000283	0.00248	CcSEcCtD
Dinoprostone—Hyperhidrosis—Irinotecan—stomach cancer	0.000281	0.00246	CcSEcCtD
Dinoprostone—Pharyngitis—Docetaxel—stomach cancer	0.000281	0.00246	CcSEcCtD
Dinoprostone—Anaphylactic shock—Fluorouracil—stomach cancer	0.000278	0.00244	CcSEcCtD
Dinoprostone—Hot flush—Doxorubicin—stomach cancer	0.000273	0.00239	CcSEcCtD
Dinoprostone—Pharyngitis—Capecitabine—stomach cancer	0.000272	0.00238	CcSEcCtD
Dinoprostone—Tachycardia—Fluorouracil—stomach cancer	0.000272	0.00238	CcSEcCtD
Dinoprostone—Hypotension—Irinotecan—stomach cancer	0.000272	0.00238	CcSEcCtD
Dinoprostone—Menopausal symptoms—Doxorubicin—stomach cancer	0.00027	0.00237	CcSEcCtD
Dinoprostone—Anaphylactoid reaction—Doxorubicin—stomach cancer	0.000264	0.00231	CcSEcCtD
Dinoprostone—Flushing—Docetaxel—stomach cancer	0.000262	0.0023	CcSEcCtD
Dinoprostone—Cardiac arrest—Epirubicin—stomach cancer	0.000262	0.0023	CcSEcCtD
Dinoprostone—Paraesthesia—Irinotecan—stomach cancer	0.000261	0.00229	CcSEcCtD
Dinoprostone—Hypotension—Fluorouracil—stomach cancer	0.00026	0.00228	CcSEcCtD
Dinoprostone—Dyspnoea—Irinotecan—stomach cancer	0.000259	0.00227	CcSEcCtD
Dinoprostone—Angiopathy—Docetaxel—stomach cancer	0.000257	0.00225	CcSEcCtD
Dinoprostone—Dehydration—Epirubicin—stomach cancer	0.000256	0.00225	CcSEcCtD
Dinoprostone—Immune system disorder—Docetaxel—stomach cancer	0.000255	0.00224	CcSEcCtD
Dinoprostone—Asthma—Methotrexate—stomach cancer	0.000255	0.00223	CcSEcCtD
Dinoprostone—Flushing—Capecitabine—stomach cancer	0.000254	0.00223	CcSEcCtD
Dinoprostone—Chills—Docetaxel—stomach cancer	0.000254	0.00223	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Fluorouracil—stomach cancer	0.000254	0.00222	CcSEcCtD
Dinoprostone—Arrhythmia—Docetaxel—stomach cancer	0.000253	0.00222	CcSEcCtD
Dinoprostone—Paraesthesia—Fluorouracil—stomach cancer	0.00025	0.00219	CcSEcCtD
Dinoprostone—Pain—Irinotecan—stomach cancer	0.000249	0.00218	CcSEcCtD
Dinoprostone—Angiopathy—Capecitabine—stomach cancer	0.000248	0.00218	CcSEcCtD
Dinoprostone—Dyspnoea—Fluorouracil—stomach cancer	0.000248	0.00218	CcSEcCtD
Dinoprostone—Immune system disorder—Capecitabine—stomach cancer	0.000247	0.00217	CcSEcCtD
Dinoprostone—Chills—Capecitabine—stomach cancer	0.000246	0.00215	CcSEcCtD
Dinoprostone—Arrhythmia—Capecitabine—stomach cancer	0.000245	0.00215	CcSEcCtD
Dinoprostone—Cardiac arrest—Doxorubicin—stomach cancer	0.000243	0.00213	CcSEcCtD
Dinoprostone—Asthma—Epirubicin—stomach cancer	0.000238	0.00209	CcSEcCtD
Dinoprostone—Back pain—Docetaxel—stomach cancer	0.000238	0.00209	CcSEcCtD
Dinoprostone—Pain—Fluorouracil—stomach cancer	0.000238	0.00209	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Irinotecan—stomach cancer	0.000238	0.00208	CcSEcCtD
Dinoprostone—Dehydration—Doxorubicin—stomach cancer	0.000237	0.00208	CcSEcCtD
Dinoprostone—Muscle spasms—Docetaxel—stomach cancer	0.000237	0.00208	CcSEcCtD
Dinoprostone—Back pain—Capecitabine—stomach cancer	0.000231	0.00202	CcSEcCtD
Dinoprostone—Body temperature increased—Irinotecan—stomach cancer	0.00023	0.00202	CcSEcCtD
Dinoprostone—Abdominal pain—Irinotecan—stomach cancer	0.00023	0.00202	CcSEcCtD
Dinoprostone—Muscle spasms—Capecitabine—stomach cancer	0.000229	0.00201	CcSEcCtD
Dinoprostone—Vision blurred—Capecitabine—stomach cancer	0.000225	0.00197	CcSEcCtD
Dinoprostone—Tremor—Capecitabine—stomach cancer	0.000223	0.00196	CcSEcCtD
Dinoprostone—Syncope—Docetaxel—stomach cancer	0.000221	0.00194	CcSEcCtD
Dinoprostone—Asthma—Doxorubicin—stomach cancer	0.000221	0.00193	CcSEcCtD
Dinoprostone—Body temperature increased—Fluorouracil—stomach cancer	0.00022	0.00193	CcSEcCtD
Dinoprostone—Loss of consciousness—Docetaxel—stomach cancer	0.000216	0.0019	CcSEcCtD
Dinoprostone—Cough—Docetaxel—stomach cancer	0.000215	0.00188	CcSEcCtD
Dinoprostone—Hypersensitivity—Irinotecan—stomach cancer	0.000214	0.00188	CcSEcCtD
Dinoprostone—Syncope—Capecitabine—stomach cancer	0.000214	0.00187	CcSEcCtD
Dinoprostone—Hypertension—Docetaxel—stomach cancer	0.000213	0.00186	CcSEcCtD
Dinoprostone—Myalgia—Docetaxel—stomach cancer	0.00021	0.00184	CcSEcCtD
Dinoprostone—Arthralgia—Docetaxel—stomach cancer	0.00021	0.00184	CcSEcCtD
Dinoprostone—Chest pain—Docetaxel—stomach cancer	0.00021	0.00184	CcSEcCtD
Dinoprostone—Loss of consciousness—Capecitabine—stomach cancer	0.00021	0.00184	CcSEcCtD
Dinoprostone—Asthenia—Irinotecan—stomach cancer	0.000209	0.00183	CcSEcCtD
Dinoprostone—Cough—Capecitabine—stomach cancer	0.000208	0.00182	CcSEcCtD
Dinoprostone—Hypertension—Capecitabine—stomach cancer	0.000206	0.00181	CcSEcCtD
Dinoprostone—Hypersensitivity—Fluorouracil—stomach cancer	0.000205	0.0018	CcSEcCtD
Dinoprostone—Arthralgia—Capecitabine—stomach cancer	0.000203	0.00178	CcSEcCtD
Dinoprostone—Chest pain—Capecitabine—stomach cancer	0.000203	0.00178	CcSEcCtD
Dinoprostone—Myalgia—Capecitabine—stomach cancer	0.000203	0.00178	CcSEcCtD
Dinoprostone—Pharyngitis—Methotrexate—stomach cancer	0.000202	0.00177	CcSEcCtD
Dinoprostone—Anaphylactic shock—Docetaxel—stomach cancer	0.000201	0.00176	CcSEcCtD
Dinoprostone—Diarrhoea—Irinotecan—stomach cancer	0.000199	0.00174	CcSEcCtD
Dinoprostone—Shock—Docetaxel—stomach cancer	0.000198	0.00173	CcSEcCtD
Dinoprostone—Tachycardia—Docetaxel—stomach cancer	0.000196	0.00172	CcSEcCtD
Dinoprostone—Dizziness—Irinotecan—stomach cancer	0.000192	0.00169	CcSEcCtD
Dinoprostone—Shock—Capecitabine—stomach cancer	0.000191	0.00168	CcSEcCtD
Dinoprostone—Diarrhoea—Fluorouracil—stomach cancer	0.00019	0.00167	CcSEcCtD
Dinoprostone—Tachycardia—Capecitabine—stomach cancer	0.00019	0.00167	CcSEcCtD
Dinoprostone—Pharyngitis—Epirubicin—stomach cancer	0.000189	0.00166	CcSEcCtD
Dinoprostone—Hyperhidrosis—Capecitabine—stomach cancer	0.000188	0.00165	CcSEcCtD
Dinoprostone—Hypotension—Docetaxel—stomach cancer	0.000188	0.00165	CcSEcCtD
Dinoprostone—Angiopathy—Methotrexate—stomach cancer	0.000185	0.00162	CcSEcCtD
Dinoprostone—Vomiting—Irinotecan—stomach cancer	0.000185	0.00162	CcSEcCtD
Dinoprostone—Immune system disorder—Methotrexate—stomach cancer	0.000184	0.00161	CcSEcCtD
Dinoprostone—Dizziness—Fluorouracil—stomach cancer	0.000184	0.00161	CcSEcCtD
Dinoprostone—Rash—Irinotecan—stomach cancer	0.000183	0.00161	CcSEcCtD
Dinoprostone—Dermatitis—Irinotecan—stomach cancer	0.000183	0.00161	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000183	0.00161	CcSEcCtD
Dinoprostone—Chills—Methotrexate—stomach cancer	0.000183	0.0016	CcSEcCtD
Dinoprostone—Headache—Irinotecan—stomach cancer	0.000182	0.0016	CcSEcCtD
Dinoprostone—Hypotension—Capecitabine—stomach cancer	0.000182	0.00159	CcSEcCtD
Dinoprostone—Paraesthesia—Docetaxel—stomach cancer	0.00018	0.00158	CcSEcCtD
Dinoprostone—Dyspnoea—Docetaxel—stomach cancer	0.000179	0.00157	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000177	0.00155	CcSEcCtD
Dinoprostone—Flushing—Epirubicin—stomach cancer	0.000177	0.00155	CcSEcCtD
Dinoprostone—Vomiting—Fluorouracil—stomach cancer	0.000177	0.00155	CcSEcCtD
Dinoprostone—Rash—Fluorouracil—stomach cancer	0.000176	0.00154	CcSEcCtD
Dinoprostone—Dermatitis—Fluorouracil—stomach cancer	0.000175	0.00154	CcSEcCtD
Dinoprostone—Pharyngitis—Doxorubicin—stomach cancer	0.000175	0.00154	CcSEcCtD
Dinoprostone—Paraesthesia—Capecitabine—stomach cancer	0.000175	0.00153	CcSEcCtD
Dinoprostone—Headache—Fluorouracil—stomach cancer	0.000174	0.00153	CcSEcCtD
Dinoprostone—Dyspnoea—Capecitabine—stomach cancer	0.000173	0.00152	CcSEcCtD
Dinoprostone—Angiopathy—Epirubicin—stomach cancer	0.000173	0.00152	CcSEcCtD
Dinoprostone—Nausea—Irinotecan—stomach cancer	0.000173	0.00151	CcSEcCtD
Dinoprostone—Immune system disorder—Epirubicin—stomach cancer	0.000172	0.00151	CcSEcCtD
Dinoprostone—Pain—Docetaxel—stomach cancer	0.000172	0.00151	CcSEcCtD
Dinoprostone—Back pain—Methotrexate—stomach cancer	0.000172	0.00151	CcSEcCtD
Dinoprostone—Chills—Epirubicin—stomach cancer	0.000171	0.0015	CcSEcCtD
Dinoprostone—Arrhythmia—Epirubicin—stomach cancer	0.00017	0.00149	CcSEcCtD
Dinoprostone—Vision blurred—Methotrexate—stomach cancer	0.000167	0.00147	CcSEcCtD
Dinoprostone—Pain—Capecitabine—stomach cancer	0.000166	0.00146	CcSEcCtD
Dinoprostone—Nausea—Fluorouracil—stomach cancer	0.000165	0.00145	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Docetaxel—stomach cancer	0.000164	0.00144	CcSEcCtD
Dinoprostone—Flushing—Doxorubicin—stomach cancer	0.000164	0.00144	CcSEcCtD
Dinoprostone—Tension—Epirubicin—stomach cancer	0.000163	0.00143	CcSEcCtD
Dinoprostone—Back pain—Epirubicin—stomach cancer	0.000161	0.00141	CcSEcCtD
Dinoprostone—Angiopathy—Doxorubicin—stomach cancer	0.00016	0.0014	CcSEcCtD
Dinoprostone—Muscle spasms—Epirubicin—stomach cancer	0.00016	0.0014	CcSEcCtD
Dinoprostone—Immune system disorder—Doxorubicin—stomach cancer	0.000159	0.0014	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Capecitabine—stomach cancer	0.000159	0.0014	CcSEcCtD
Dinoprostone—Abdominal pain—Docetaxel—stomach cancer	0.000159	0.00139	CcSEcCtD
Dinoprostone—Body temperature increased—Docetaxel—stomach cancer	0.000159	0.00139	CcSEcCtD
Dinoprostone—Chills—Doxorubicin—stomach cancer	0.000158	0.00139	CcSEcCtD
Dinoprostone—Arrhythmia—Doxorubicin—stomach cancer	0.000158	0.00138	CcSEcCtD
Dinoprostone—Vision blurred—Epirubicin—stomach cancer	0.000156	0.00137	CcSEcCtD
Dinoprostone—Cough—Methotrexate—stomach cancer	0.000155	0.00136	CcSEcCtD
Dinoprostone—Body temperature increased—Capecitabine—stomach cancer	0.000154	0.00135	CcSEcCtD
Dinoprostone—Abdominal pain—Capecitabine—stomach cancer	0.000154	0.00135	CcSEcCtD
Dinoprostone—Myalgia—Methotrexate—stomach cancer	0.000151	0.00133	CcSEcCtD
Dinoprostone—Arthralgia—Methotrexate—stomach cancer	0.000151	0.00133	CcSEcCtD
Dinoprostone—Chest pain—Methotrexate—stomach cancer	0.000151	0.00133	CcSEcCtD
Dinoprostone—Tension—Doxorubicin—stomach cancer	0.000151	0.00132	CcSEcCtD
Dinoprostone—Syncope—Epirubicin—stomach cancer	0.000149	0.00131	CcSEcCtD
Dinoprostone—Back pain—Doxorubicin—stomach cancer	0.000149	0.0013	CcSEcCtD
Dinoprostone—Hypersensitivity—Docetaxel—stomach cancer	0.000148	0.0013	CcSEcCtD
Dinoprostone—Muscle spasms—Doxorubicin—stomach cancer	0.000148	0.0013	CcSEcCtD
Dinoprostone—Loss of consciousness—Epirubicin—stomach cancer	0.000146	0.00128	CcSEcCtD
Dinoprostone—Cough—Epirubicin—stomach cancer	0.000145	0.00127	CcSEcCtD
Dinoprostone—Anaphylactic shock—Methotrexate—stomach cancer	0.000145	0.00127	CcSEcCtD
Dinoprostone—Vision blurred—Doxorubicin—stomach cancer	0.000145	0.00127	CcSEcCtD
Dinoprostone—Asthenia—Docetaxel—stomach cancer	0.000144	0.00126	CcSEcCtD
Dinoprostone—Hypertension—Epirubicin—stomach cancer	0.000143	0.00126	CcSEcCtD
Dinoprostone—Hypersensitivity—Capecitabine—stomach cancer	0.000143	0.00126	CcSEcCtD
Dinoprostone—Arthralgia—Epirubicin—stomach cancer	0.000141	0.00124	CcSEcCtD
Dinoprostone—Myalgia—Epirubicin—stomach cancer	0.000141	0.00124	CcSEcCtD
Dinoprostone—Chest pain—Epirubicin—stomach cancer	0.000141	0.00124	CcSEcCtD
Dinoprostone—Hyperhidrosis—Methotrexate—stomach cancer	0.00014	0.00123	CcSEcCtD
Dinoprostone—Asthenia—Capecitabine—stomach cancer	0.00014	0.00122	CcSEcCtD
Dinoprostone—Syncope—Doxorubicin—stomach cancer	0.000138	0.00121	CcSEcCtD
Dinoprostone—Diarrhoea—Docetaxel—stomach cancer	0.000137	0.00121	CcSEcCtD
Dinoprostone—Anaphylactic shock—Epirubicin—stomach cancer	0.000136	0.00119	CcSEcCtD
Dinoprostone—Hypotension—Methotrexate—stomach cancer	0.000135	0.00119	CcSEcCtD
Dinoprostone—Loss of consciousness—Doxorubicin—stomach cancer	0.000135	0.00118	CcSEcCtD
Dinoprostone—Cough—Doxorubicin—stomach cancer	0.000134	0.00118	CcSEcCtD
Dinoprostone—Shock—Epirubicin—stomach cancer	0.000133	0.00117	CcSEcCtD
Dinoprostone—Diarrhoea—Capecitabine—stomach cancer	0.000133	0.00117	CcSEcCtD
Dinoprostone—Dizziness—Docetaxel—stomach cancer	0.000133	0.00117	CcSEcCtD
Dinoprostone—Hypertension—Doxorubicin—stomach cancer	0.000133	0.00116	CcSEcCtD
Dinoprostone—Tachycardia—Epirubicin—stomach cancer	0.000132	0.00116	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000132	0.00116	CcSEcCtD
Dinoprostone—Hyperhidrosis—Epirubicin—stomach cancer	0.000131	0.00115	CcSEcCtD
Dinoprostone—Myalgia—Doxorubicin—stomach cancer	0.000131	0.00115	CcSEcCtD
Dinoprostone—Chest pain—Doxorubicin—stomach cancer	0.000131	0.00115	CcSEcCtD
Dinoprostone—Arthralgia—Doxorubicin—stomach cancer	0.000131	0.00115	CcSEcCtD
Dinoprostone—Paraesthesia—Methotrexate—stomach cancer	0.00013	0.00114	CcSEcCtD
Dinoprostone—Dyspnoea—Methotrexate—stomach cancer	0.000129	0.00113	CcSEcCtD
Dinoprostone—Dizziness—Capecitabine—stomach cancer	0.000129	0.00113	CcSEcCtD
Dinoprostone—Vomiting—Docetaxel—stomach cancer	0.000128	0.00112	CcSEcCtD
Dinoprostone—Rash—Docetaxel—stomach cancer	0.000127	0.00111	CcSEcCtD
Dinoprostone—Hypotension—Epirubicin—stomach cancer	0.000127	0.00111	CcSEcCtD
Dinoprostone—Dermatitis—Docetaxel—stomach cancer	0.000127	0.00111	CcSEcCtD
Dinoprostone—Headache—Docetaxel—stomach cancer	0.000126	0.0011	CcSEcCtD
Dinoprostone—Anaphylactic shock—Doxorubicin—stomach cancer	0.000125	0.0011	CcSEcCtD
Dinoprostone—Pain—Methotrexate—stomach cancer	0.000124	0.00109	CcSEcCtD
Dinoprostone—Vomiting—Capecitabine—stomach cancer	0.000124	0.00108	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000123	0.00108	CcSEcCtD
Dinoprostone—Shock—Doxorubicin—stomach cancer	0.000123	0.00108	CcSEcCtD
Dinoprostone—Rash—Capecitabine—stomach cancer	0.000123	0.00108	CcSEcCtD
Dinoprostone—Dermatitis—Capecitabine—stomach cancer	0.000123	0.00107	CcSEcCtD
Dinoprostone—Tachycardia—Doxorubicin—stomach cancer	0.000122	0.00107	CcSEcCtD
Dinoprostone—Headache—Capecitabine—stomach cancer	0.000122	0.00107	CcSEcCtD
Dinoprostone—Paraesthesia—Epirubicin—stomach cancer	0.000122	0.00107	CcSEcCtD
Dinoprostone—Hyperhidrosis—Doxorubicin—stomach cancer	0.000121	0.00106	CcSEcCtD
Dinoprostone—Dyspnoea—Epirubicin—stomach cancer	0.000121	0.00106	CcSEcCtD
Dinoprostone—Nausea—Docetaxel—stomach cancer	0.000119	0.00105	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Methotrexate—stomach cancer	0.000118	0.00104	CcSEcCtD
Dinoprostone—Hypotension—Doxorubicin—stomach cancer	0.000117	0.00103	CcSEcCtD
Dinoprostone—Pain—Epirubicin—stomach cancer	0.000116	0.00102	CcSEcCtD
Dinoprostone—Nausea—Capecitabine—stomach cancer	0.000116	0.00101	CcSEcCtD
Dinoprostone—Abdominal pain—Methotrexate—stomach cancer	0.000114	0.001	CcSEcCtD
Dinoprostone—Body temperature increased—Methotrexate—stomach cancer	0.000114	0.001	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000114	0.001	CcSEcCtD
Dinoprostone—Paraesthesia—Doxorubicin—stomach cancer	0.000113	0.000988	CcSEcCtD
Dinoprostone—Dyspnoea—Doxorubicin—stomach cancer	0.000112	0.000981	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Epirubicin—stomach cancer	0.000111	0.000972	CcSEcCtD
Dinoprostone—Pain—Doxorubicin—stomach cancer	0.000107	0.000941	CcSEcCtD
Dinoprostone—Abdominal pain—Epirubicin—stomach cancer	0.000107	0.00094	CcSEcCtD
Dinoprostone—Body temperature increased—Epirubicin—stomach cancer	0.000107	0.00094	CcSEcCtD
Dinoprostone—Hypersensitivity—Methotrexate—stomach cancer	0.000107	0.000936	CcSEcCtD
Dinoprostone—Asthenia—Methotrexate—stomach cancer	0.000104	0.000911	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000103	0.000899	CcSEcCtD
Dinoprostone—Hypersensitivity—Epirubicin—stomach cancer	9.99e-05	0.000876	CcSEcCtD
Dinoprostone—Abdominal pain—Doxorubicin—stomach cancer	9.91e-05	0.000869	CcSEcCtD
Dinoprostone—Body temperature increased—Doxorubicin—stomach cancer	9.91e-05	0.000869	CcSEcCtD
Dinoprostone—Diarrhoea—Methotrexate—stomach cancer	9.91e-05	0.000869	CcSEcCtD
Dinoprostone—Asthenia—Epirubicin—stomach cancer	9.72e-05	0.000853	CcSEcCtD
Dinoprostone—Dizziness—Methotrexate—stomach cancer	9.58e-05	0.00084	CcSEcCtD
Dinoprostone—Diarrhoea—Epirubicin—stomach cancer	9.27e-05	0.000813	CcSEcCtD
Dinoprostone—Hypersensitivity—Doxorubicin—stomach cancer	9.24e-05	0.00081	CcSEcCtD
Dinoprostone—Vomiting—Methotrexate—stomach cancer	9.21e-05	0.000808	CcSEcCtD
Dinoprostone—Rash—Methotrexate—stomach cancer	9.13e-05	0.000801	CcSEcCtD
Dinoprostone—Dermatitis—Methotrexate—stomach cancer	9.12e-05	0.0008	CcSEcCtD
Dinoprostone—Headache—Methotrexate—stomach cancer	9.07e-05	0.000796	CcSEcCtD
Dinoprostone—Asthenia—Doxorubicin—stomach cancer	9e-05	0.000789	CcSEcCtD
Dinoprostone—Dizziness—Epirubicin—stomach cancer	8.96e-05	0.000786	CcSEcCtD
Dinoprostone—Vomiting—Epirubicin—stomach cancer	8.62e-05	0.000756	CcSEcCtD
Dinoprostone—Nausea—Methotrexate—stomach cancer	8.6e-05	0.000755	CcSEcCtD
Dinoprostone—Diarrhoea—Doxorubicin—stomach cancer	8.58e-05	0.000753	CcSEcCtD
Dinoprostone—Rash—Epirubicin—stomach cancer	8.55e-05	0.00075	CcSEcCtD
Dinoprostone—Dermatitis—Epirubicin—stomach cancer	8.54e-05	0.000749	CcSEcCtD
Dinoprostone—Headache—Epirubicin—stomach cancer	8.49e-05	0.000745	CcSEcCtD
Dinoprostone—Dizziness—Doxorubicin—stomach cancer	8.29e-05	0.000727	CcSEcCtD
Dinoprostone—Nausea—Epirubicin—stomach cancer	8.05e-05	0.000706	CcSEcCtD
Dinoprostone—Vomiting—Doxorubicin—stomach cancer	7.97e-05	0.000699	CcSEcCtD
Dinoprostone—Rash—Doxorubicin—stomach cancer	7.91e-05	0.000694	CcSEcCtD
Dinoprostone—Dermatitis—Doxorubicin—stomach cancer	7.9e-05	0.000693	CcSEcCtD
Dinoprostone—Headache—Doxorubicin—stomach cancer	7.86e-05	0.000689	CcSEcCtD
Dinoprostone—Nausea—Doxorubicin—stomach cancer	7.45e-05	0.000653	CcSEcCtD
Dinoprostone—PTGER3—Signaling Pathways—MMP9—stomach cancer	9.35e-06	6.35e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—CD44—stomach cancer	9.34e-06	6.34e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—CDKN1A—stomach cancer	9.31e-06	6.33e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—TYMS—stomach cancer	9.24e-06	6.28e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PLIN2—stomach cancer	9.22e-06	6.26e-05	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—KRAS—stomach cancer	9.18e-06	6.24e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Transmembrane transport of small molecules—ALB—stomach cancer	9.18e-06	6.23e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—ALB—stomach cancer	9.17e-06	6.23e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PPP2R1A—stomach cancer	9.16e-06	6.22e-05	CbGpPWpGaD
Dinoprostone—PTGFR—GPCR downstream signaling—PIK3CA—stomach cancer	9.14e-06	6.21e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—GSTM1—stomach cancer	9.13e-06	6.2e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—SERPINE1—stomach cancer	9.12e-06	6.2e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Neuronal System—HRAS—stomach cancer	9.12e-06	6.19e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—VEGFA—stomach cancer	9.09e-06	6.18e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—MAPK8—stomach cancer	9.09e-06	6.17e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—CDKN1B—stomach cancer	9.07e-06	6.16e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—KRAS—stomach cancer	9.03e-06	6.13e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—STAT3—stomach cancer	9e-06	6.12e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—GSTP1—stomach cancer	8.98e-06	6.1e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CA2—stomach cancer	8.97e-06	6.09e-05	CbGpPWpGaD
Dinoprostone—PTGIR—GPCR downstream signaling—PIK3CA—stomach cancer	8.94e-06	6.08e-05	CbGpPWpGaD
Dinoprostone—PTGER1—GPCR downstream signaling—PIK3CA—stomach cancer	8.94e-06	6.08e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—SERPINE1—stomach cancer	8.93e-06	6.07e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—SERPINE1—stomach cancer	8.93e-06	6.07e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—PPARG—stomach cancer	8.93e-06	6.07e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—HMOX1—stomach cancer	8.86e-06	6.02e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—KRAS—stomach cancer	8.84e-06	6.01e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—KRAS—stomach cancer	8.84e-06	6.01e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—RHOA—stomach cancer	8.8e-06	5.98e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—NOS3—stomach cancer	8.77e-06	5.96e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—NT5E—stomach cancer	8.74e-06	5.94e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PGAM1—stomach cancer	8.74e-06	5.94e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—NOS3—stomach cancer	8.71e-06	5.92e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—CD44—stomach cancer	8.7e-06	5.91e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PPP2R1A—stomach cancer	8.66e-06	5.89e-05	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—PIK3CA—stomach cancer	8.65e-06	5.88e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—RHOA—stomach cancer	8.62e-06	5.85e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—RHOA—stomach cancer	8.62e-06	5.85e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—MAPK3—stomach cancer	8.6e-06	5.84e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—ERCC2—stomach cancer	8.59e-06	5.83e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—NOS3—stomach cancer	8.53e-06	5.79e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—NOS3—stomach cancer	8.53e-06	5.79e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Neuronal System—HRAS—stomach cancer	8.5e-06	5.77e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—GSTP1—stomach cancer	8.5e-06	5.77e-05	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—PIK3CA—stomach cancer	8.44e-06	5.73e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—VEGFA—stomach cancer	8.39e-06	5.7e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—HMOX1—stomach cancer	8.38e-06	5.69e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—CDKN1A—stomach cancer	8.37e-06	5.69e-05	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—TP53—stomach cancer	8.37e-06	5.68e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—MYC—stomach cancer	8.37e-06	5.68e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—TYMS—stomach cancer	8.35e-06	5.67e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ALDH7A1—stomach cancer	8.34e-06	5.66e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PLCE1—stomach cancer	8.34e-06	5.66e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—STAT3—stomach cancer	8.31e-06	5.64e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—PIK3CA—stomach cancer	8.3e-06	5.64e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—GSTM1—stomach cancer	8.25e-06	5.61e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—MAPK1—stomach cancer	8.19e-06	5.56e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—EGFR—stomach cancer	8.18e-06	5.56e-05	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—TP53—stomach cancer	8.16e-06	5.54e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—ERBB2—stomach cancer	8.15e-06	5.53e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—PIK3CA—stomach cancer	8.12e-06	5.52e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—PIK3CA—stomach cancer	8.12e-06	5.52e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—MTHFR—stomach cancer	8.07e-06	5.48e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—ALB—stomach cancer	8.03e-06	5.45e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—PTGS2—stomach cancer	8.02e-06	5.45e-05	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—HRAS—stomach cancer	8e-06	5.44e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—UMPS—stomach cancer	7.99e-06	5.43e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—ERBB2—stomach cancer	7.98e-06	5.42e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—ERBB2—stomach cancer	7.98e-06	5.42e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—MAPK3—stomach cancer	7.94e-06	5.39e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PPP2R1A—stomach cancer	7.94e-06	5.39e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—TYMS—stomach cancer	7.9e-06	5.37e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—GSTM1—stomach cancer	7.81e-06	5.3e-05	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—HRAS—stomach cancer	7.8e-06	5.3e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—GSTP1—stomach cancer	7.79e-06	5.29e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—ERCC2—stomach cancer	7.76e-06	5.27e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—KRAS—stomach cancer	7.73e-06	5.25e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CXCL8—stomach cancer	7.73e-06	5.25e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—MYC—stomach cancer	7.72e-06	5.25e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—HMOX1—stomach cancer	7.68e-06	5.22e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—NOS3—stomach cancer	7.68e-06	5.22e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—HRAS—stomach cancer	7.68e-06	5.21e-05	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—IL6—stomach cancer	7.66e-06	5.2e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CXCL8—stomach cancer	7.56e-06	5.14e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CXCL8—stomach cancer	7.56e-06	5.14e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—MAPK1—stomach cancer	7.55e-06	5.13e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—EGFR—stomach cancer	7.55e-06	5.13e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CDKN1B—stomach cancer	7.55e-06	5.13e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—HRAS—stomach cancer	7.51e-06	5.1e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—HRAS—stomach cancer	7.51e-06	5.1e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—STAT3—stomach cancer	7.47e-06	5.07e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—CAV1—stomach cancer	7.44e-06	5.06e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PDHA1—stomach cancer	7.43e-06	5.05e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ECHS1—stomach cancer	7.43e-06	5.05e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—APOA1—stomach cancer	7.43e-06	5.05e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PPP2R1A—stomach cancer	7.4e-06	5.03e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CDKN1B—stomach cancer	7.39e-06	5.02e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CDKN1B—stomach cancer	7.39e-06	5.02e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—IL6—stomach cancer	7.35e-06	4.99e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—ERCC2—stomach cancer	7.34e-06	4.99e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—MTHFR—stomach cancer	7.29e-06	4.95e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—GSTP1—stomach cancer	7.26e-06	4.93e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—TYMS—stomach cancer	7.24e-06	4.92e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CCND1—stomach cancer	7.2e-06	4.89e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—IL6—stomach cancer	7.19e-06	4.89e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—IL6—stomach cancer	7.19e-06	4.89e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—JUN—stomach cancer	7.18e-06	4.88e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—HMOX1—stomach cancer	7.16e-06	4.86e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—GSTM1—stomach cancer	7.16e-06	4.86e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—MAPK3—stomach cancer	7.14e-06	4.85e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—KRAS—stomach cancer	7.13e-06	4.85e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	7.11e-06	4.83e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—PIK3CA—stomach cancer	7.1e-06	4.82e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CCND1—stomach cancer	7.05e-06	4.79e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CCND1—stomach cancer	7.05e-06	4.79e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—JUN—stomach cancer	7.03e-06	4.78e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—JUN—stomach cancer	7.03e-06	4.78e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—PTGS2—stomach cancer	7.02e-06	4.77e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—MMP9—stomach cancer	6.99e-06	4.75e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—TYMP—stomach cancer	6.99e-06	4.75e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—FADS1—stomach cancer	6.99e-06	4.75e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CDKN1A—stomach cancer	6.96e-06	4.73e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—MYC—stomach cancer	6.94e-06	4.71e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—MTHFR—stomach cancer	6.9e-06	4.69e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—TP53—stomach cancer	6.87e-06	4.67e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—MMP9—stomach cancer	6.84e-06	4.65e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—MMP9—stomach cancer	6.84e-06	4.65e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CDKN1A—stomach cancer	6.82e-06	4.63e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CDKN1A—stomach cancer	6.82e-06	4.63e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—MAPK8—stomach cancer	6.8e-06	4.62e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—MAPK1—stomach cancer	6.79e-06	4.61e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—EGFR—stomach cancer	6.79e-06	4.61e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—TYMS—stomach cancer	6.75e-06	4.58e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—ERCC2—stomach cancer	6.73e-06	4.57e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—CAV1—stomach cancer	6.73e-06	4.57e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—APOA1—stomach cancer	6.71e-06	4.56e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—GSTM1—stomach cancer	6.67e-06	4.53e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—MAPK8—stomach cancer	6.65e-06	4.52e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—MAPK8—stomach cancer	6.65e-06	4.52e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—HRAS—stomach cancer	6.57e-06	4.46e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—PIK3CA—stomach cancer	6.56e-06	4.45e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PPARG—stomach cancer	6.54e-06	4.45e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—SREBF2—stomach cancer	6.54e-06	4.44e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—RORA—stomach cancer	6.47e-06	4.39e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	6.43e-06	4.37e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—KRAS—stomach cancer	6.41e-06	4.36e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—CAV1—stomach cancer	6.37e-06	4.32e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—APOA1—stomach cancer	6.35e-06	4.31e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—TP53—stomach cancer	6.34e-06	4.31e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—MTHFR—stomach cancer	6.32e-06	4.3e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—IL6—stomach cancer	6.29e-06	4.27e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—VEGFA—stomach cancer	6.28e-06	4.26e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—ERCC2—stomach cancer	6.27e-06	4.26e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—STAT3—stomach cancer	6.21e-06	4.22e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—VEGFA—stomach cancer	6.14e-06	4.17e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—VEGFA—stomach cancer	6.14e-06	4.17e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—STAT3—stomach cancer	6.08e-06	4.13e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—STAT3—stomach cancer	6.08e-06	4.13e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	6.08e-06	4.13e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—HRAS—stomach cancer	6.06e-06	4.12e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ALDOB—stomach cancer	6.06e-06	4.12e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—MAPK3—stomach cancer	5.94e-06	4.03e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PPARG—stomach cancer	5.92e-06	4.02e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—MTHFR—stomach cancer	5.89e-06	4e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—PIK3CA—stomach cancer	5.89e-06	4e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—ALB—stomach cancer	5.88e-06	4e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—CAV1—stomach cancer	5.83e-06	3.96e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—APOA1—stomach cancer	5.82e-06	3.95e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—MAPK3—stomach cancer	5.81e-06	3.95e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—MAPK3—stomach cancer	5.81e-06	3.95e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—IL6—stomach cancer	5.8e-06	3.94e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—MYC—stomach cancer	5.77e-06	3.92e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	5.71e-06	3.88e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	5.7e-06	3.87e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—MYC—stomach cancer	5.65e-06	3.84e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—MYC—stomach cancer	5.65e-06	3.84e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—MAPK1—stomach cancer	5.65e-06	3.84e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—EGFR—stomach cancer	5.65e-06	3.84e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ALOX5—stomach cancer	5.63e-06	3.83e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—NOS3—stomach cancer	5.63e-06	3.82e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PPARG—stomach cancer	5.6e-06	3.8e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—DPYD—stomach cancer	5.54e-06	3.76e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—MAPK1—stomach cancer	5.53e-06	3.76e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—MAPK1—stomach cancer	5.53e-06	3.76e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—EGFR—stomach cancer	5.53e-06	3.76e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—EGFR—stomach cancer	5.53e-06	3.76e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—HRAS—stomach cancer	5.45e-06	3.7e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—CAV1—stomach cancer	5.44e-06	3.69e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—APOA1—stomach cancer	5.43e-06	3.69e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—KRAS—stomach cancer	5.34e-06	3.62e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—ALB—stomach cancer	5.32e-06	3.61e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—KRAS—stomach cancer	5.22e-06	3.55e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—KRAS—stomach cancer	5.22e-06	3.55e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—IL6—stomach cancer	5.22e-06	3.54e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PTGS2—stomach cancer	5.15e-06	3.5e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PPARG—stomach cancer	5.13e-06	3.48e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—NOS3—stomach cancer	5.09e-06	3.46e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—ALB—stomach cancer	5.03e-06	3.42e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	5.02e-06	3.41e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—PIK3CA—stomach cancer	4.93e-06	3.35e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—PIK3CA—stomach cancer	4.9e-06	3.33e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GSTT1—stomach cancer	4.9e-06	3.33e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CYP2A6—stomach cancer	4.84e-06	3.29e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—NOS3—stomach cancer	4.81e-06	3.27e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—PIK3CA—stomach cancer	4.8e-06	3.26e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—PIK3CA—stomach cancer	4.8e-06	3.26e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PPARG—stomach cancer	4.78e-06	3.25e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—TP53—stomach cancer	4.74e-06	3.22e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—AKR1C3—stomach cancer	4.71e-06	3.2e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PTGS2—stomach cancer	4.65e-06	3.16e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—TP53—stomach cancer	4.64e-06	3.15e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—TP53—stomach cancer	4.64e-06	3.15e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—ALB—stomach cancer	4.61e-06	3.13e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ENO1—stomach cancer	4.59e-06	3.12e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—HRAS—stomach cancer	4.53e-06	3.08e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	4.52e-06	3.07e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—HRAS—stomach cancer	4.44e-06	3.02e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—HRAS—stomach cancer	4.44e-06	3.02e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—NOS3—stomach cancer	4.41e-06	3e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PTGS2—stomach cancer	4.4e-06	2.99e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—IL6—stomach cancer	4.34e-06	2.95e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—PIK3CA—stomach cancer	4.32e-06	2.94e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—ALB—stomach cancer	4.3e-06	2.92e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—IL6—stomach cancer	4.25e-06	2.89e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—IL6—stomach cancer	4.25e-06	2.89e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—NOS3—stomach cancer	4.11e-06	2.79e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CD44—stomach cancer	4.07e-06	2.77e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PTGS2—stomach cancer	4.03e-06	2.74e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	3.95e-06	2.68e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PTGS2—stomach cancer	3.76e-06	2.55e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PPP2R1A—stomach cancer	3.46e-06	2.35e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GSTP1—stomach cancer	3.4e-06	2.31e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—HMOX1—stomach cancer	3.35e-06	2.28e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PIK3CA—stomach cancer	3.17e-06	2.15e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—TYMS—stomach cancer	3.16e-06	2.14e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GSTM1—stomach cancer	3.12e-06	2.12e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ERCC2—stomach cancer	2.93e-06	1.99e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PIK3CA—stomach cancer	2.86e-06	1.94e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—MTHFR—stomach cancer	2.76e-06	1.87e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PIK3CA—stomach cancer	2.71e-06	1.84e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CAV1—stomach cancer	2.54e-06	1.73e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—APOA1—stomach cancer	2.54e-06	1.72e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PIK3CA—stomach cancer	2.48e-06	1.69e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.43e-06	1.65e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PIK3CA—stomach cancer	2.31e-06	1.57e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PPARG—stomach cancer	2.24e-06	1.52e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ALB—stomach cancer	2.01e-06	1.37e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—NOS3—stomach cancer	1.92e-06	1.31e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PTGS2—stomach cancer	1.76e-06	1.2e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PIK3CA—stomach cancer	1.08e-06	7.35e-06	CbGpPWpGaD
